5-year survival outcomes in patients (pts) with advanced melanoma treated with pembrolizumab (pembro) in KEYNOTE-001.
暂无分享，去创建一个
J. Wolchok | H. Zarour | A. Ribas | F. Hodi | P. Hersey | N. Ibrahim | A. Patnaik | A. Daud | R. Kefford | C. Robert | R. Joseph | O. Hamid | J. Weber | W. Hwu | A. Joshua | R. Dronca | T. Mitchell | E. Jensen | S. Ahsan